PharmGen Science

PharmGen Science Rule of 40

The Rule of 40 of PharmGen Science (004720.KS) as of Oct 12, 2026 is 4.50 %. In the previous year, Rule of 40 was 8.92 % — a change of -49.51% (lower).

Rule of 40

4.50 %

YoY

-49.51%

Last updated:

Rule of 40 of PharmGen Science is 2025 4.50 % . Rule of 40 of PharmGen Science was 2024 8.92 % . It decreases by -49.51% lower compared to the previous year.

The PharmGen Science Rule of 40 history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Rule of 40
Date
Rule of 40
Jan 1, 2017
19.19 KRW
Jan 1, 2018
17.12 KRW
Jan 1, 2019
8.28 KRW
Jan 1, 2020
13.33 KRW
Jan 1, 2021
9.22 KRW
Jan 1, 2023
15.97 KRW
Jan 1, 2024
8.92 KRW
Jan 1, 2025
4.50 KRW
The PharmGen Science Rule of 40 history
YEARRule of 40YoY
4.50 %-49.51%
8.92 %-44.18%
15.97 %+73.21%
9.22 %-30.82%
13.33 %+60.92%
8.28 %-51.61%
17.12 %-10.80%
19.19 %-23.84%
25.20 %-42.91%
44.14 %—
Access this data via the Eulerpool API
Get Free API Key

PharmGen Science Stock analysis

What does PharmGen Science do? PharmGen Science is one of the most popular companies on Eulerpool.

Frequently Asked Questions about PharmGen Science stock

Rule of 40 of PharmGen Science is 4.50 % in 2025.

On Eulerpool you can find the complete historical development of Rule of 40 PharmGen Science since 2006 – with annual values, charts, and detailed analysis.

The Rule of 40 states that a company's revenue growth rate plus profit margin should exceed 40%. It is widely used to evaluate SaaS and high-growth companies.

Access this data via the Eulerpool API
Get Free API Key

Quality — PharmGen Science

AAQSPiotroski F-ScoreAltman Z-ScoreGraham NumberRule of 40

All Key Metrics — PharmGen Science